Home › NDC Lookup › RxCUI directory › RxCUI 999986

Amlodipine 10 MG / hydrochlorothiazide 12.5 MG / olmesartan medoxomil 40 MG Oral Tablet — RxCUI 999986

RxNorm drug concept · Semantic clinical drug
RxCUI 999986 Semantic clinical drug · SCD ● Current RxNorm concept 37 FDA products 77 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI999986
Official nameAmlodipine 10 MG / hydrochlorothiazide 12.5 MG / olmesartan medoxomil 40 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asAmlodipine 10 MG / HCTZ 12.5 MG / Olmesartan medoxomil 40 MG Oral Tablet; amlodipine (as amlodipine besylate) 10 MG / hydrochlorothiazide 12.5 MG / olmesartan medoxomil 40 MG Oral Tablet
FDA products mapped37
Package NDCs mapped77
Reported Medicaid activity (SDUD)11,527 prescriptions · 20 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Olmesartan: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Olmesartan is used to treat high blood pressure (hypertension) in adults and in kids as young as six years old. It works by relaxing your blood vessels so your heart doesn't have t...
  • No — this is one of the most important things to know about olmesartan. It can cause very serious harm to an unborn baby, including kidney failure and even death, especially after...
  • Can I take this if I'm pregnant or trying to get pregnant?
  • Dizziness is the most commonly reported side effect — it happens in about 3 out of 100 people in clinical trials. It's most likely when you first start the medicine, especially if...
📖 Read our full Olmesartan guide →

🕸️ Concept Web — How Amlodipine 10 MG / hydrochlorothiazide 12.5 MG /... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Amlodipine 10 MG / hydrochlorothiazide 12.5 MG / olmesartan medoxomil 40 MG Oral Tablet RxCUI 999986

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 5

    The active substance itself — no strength, form, or brand attached yet.

    • Amlodipine 17767
    • Hydrochlorothiazide 5487
    • Olmesartan 321064
    • Amlodipine / hydrochlorothiazide / olmesartan 1008801
    • Olmesartan medoxomil 118463
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Tribenzor 1372732
  3. Dose forms 13

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Amlodipine / hydrochlorothiazide / olmesartan Oral Tablet 999966
    • Amlodipine / hydrochlorothiazide / olmesartan medoxomil Oral Tablet 2648650
    • Amlodipine / hydrochlorothiazide / olmesartan Oral Product 1152277
    • Amlodipine / hydrochlorothiazide / olmesartan Pill 1152278
    • Amlodipine / hydrochlorothiazide / olmesartan medoxomil Oral Product 2663535
    • Amlodipine / hydrochlorothiazide / olmesartan medoxomil Pill 2659409
    • Amlodipine / hydrochlorothiazide / olmesartan Oral Tablet [Tribenzor] 999970
    • Amlodipine / hydrochlorothiazide / olmesartan medoxomil Oral Tablet [Tribenzor] 2658663
    • +5 more in this family
  4. Clinical & branded drugs 5

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 19 of 24 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Amlodipine 10 MG SCDC · 329526
  • Hydrochlorothiazide 12.5 MG SCDC · 316047
  • Olmesartan medoxomil 40 MG SCDC · 359114
  • Amlodipine / hydrochlorothiazide / olmesartan Oral Tablet SCDF · 999966
  • Amlodipine / hydrochlorothiazide / olmesartan medoxomil Oral Tablet SCDFP · 2648650
  • Amlodipine / hydrochlorothiazide / olmesartan Oral Product SCDG · 1152277
  • Amlodipine / hydrochlorothiazide / olmesartan Pill SCDG · 1152278
  • Amlodipine / hydrochlorothiazide / olmesartan medoxomil Oral Product SCDGP · 2663535
  • Amlodipine / hydrochlorothiazide / olmesartan medoxomil Pill SCDGP · 2659409

Brand-Name Concepts

📦 FDA Products & Package NDCs

37 products · 77 package NDCs
77 package NDCs map to RxCUI 999986 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00093-5002-56 30 TABLET, FILM COATED in 1 BOTTLE (0093-5002-56) Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide Teva Pharmaceuticals USA, Inc. 2016-11-14
00093-5003-56 30 TABLET, FILM COATED in 1 BOTTLE (0093-5003-56) Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide Teva Pharmaceuticals USA, Inc. 2016-11-14
00093-5004-56 30 TABLET, FILM COATED in 1 BOTTLE (0093-5004-56) Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide Teva Pharmaceuticals USA, Inc. 2016-11-14
00093-5005-56 30 TABLET, FILM COATED in 1 BOTTLE (0093-5005-56) Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide Teva Pharmaceuticals USA, Inc. 2016-11-14
00093-5006-56 30 TABLET, FILM COATED in 1 BOTTLE (0093-5006-56) Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide Teva Pharmaceuticals USA, Inc. 2016-11-14
00713-0874-30 30 TABLET, FILM COATED in 1 BOTTLE (0713-0874-30) Tribenzor Cosette Pharmaceuticals, Inc. 2022-09-01
00713-0875-30 30 TABLET, FILM COATED in 1 BOTTLE (0713-0875-30) Tribenzor Cosette Pharmaceuticals, Inc. 2022-09-01
00713-0876-30 30 TABLET, FILM COATED in 1 BOTTLE (0713-0876-30) Tribenzor Cosette Pharmaceuticals, Inc. 2022-09-01
00713-0877-30 30 TABLET, FILM COATED in 1 BOTTLE (0713-0877-30) Tribenzor Cosette Pharmaceuticals, Inc. 2022-09-01
00713-0878-30 30 TABLET, FILM COATED in 1 BOTTLE (0713-0878-30) Tribenzor Cosette Pharmaceuticals, Inc. 2022-09-01
31722-0892-30 30 TABLET, FILM COATED in 1 BOTTLE (31722-892-30) Olmesartan medoxomil, amlodipine and hydrochlorothiazide Camber Pharmaceuticals, Inc. 2025-10-06
31722-0892-32 10 BLISTER PACK in 1 CARTON (31722-892-32) / 10 TABLET, FIL... Olmesartan medoxomil, amlodipine and hydrochlorothiazide Camber Pharmaceuticals, Inc. 2025-10-06
31722-0892-90 90 TABLET, FILM COATED in 1 BOTTLE (31722-892-90) Olmesartan medoxomil, amlodipine and hydrochlorothiazide Camber Pharmaceuticals, Inc. 2025-10-06
31722-0893-30 30 TABLET, FILM COATED in 1 BOTTLE (31722-893-30) Olmesartan medoxomil, amlodipine and hydrochlorothiazide Camber Pharmaceuticals, Inc. 2025-10-06
31722-0893-32 10 BLISTER PACK in 1 CARTON (31722-893-32) / 8 TABLET, FILM... Olmesartan medoxomil, amlodipine and hydrochlorothiazide Camber Pharmaceuticals, Inc. 2025-10-06
31722-0893-90 90 TABLET, FILM COATED in 1 BOTTLE (31722-893-90) Olmesartan medoxomil, amlodipine and hydrochlorothiazide Camber Pharmaceuticals, Inc. 2025-10-06
31722-0894-30 30 TABLET, FILM COATED in 1 BOTTLE (31722-894-30) Olmesartan medoxomil, amlodipine and hydrochlorothiazide Camber Pharmaceuticals, Inc. 2025-10-06
31722-0894-32 10 BLISTER PACK in 1 CARTON (31722-894-32) / 10 TABLET, FIL... Olmesartan medoxomil, amlodipine and hydrochlorothiazide Camber Pharmaceuticals, Inc. 2025-10-06
31722-0894-90 90 TABLET, FILM COATED in 1 BOTTLE (31722-894-90) Olmesartan medoxomil, amlodipine and hydrochlorothiazide Camber Pharmaceuticals, Inc. 2025-10-06
31722-0895-30 30 TABLET, FILM COATED in 1 BOTTLE (31722-895-30) Olmesartan medoxomil, amlodipine and hydrochlorothiazide Camber Pharmaceuticals, Inc. 2025-10-06
31722-0895-32 10 BLISTER PACK in 1 CARTON (31722-895-32) / 8 TABLET, FILM... Olmesartan medoxomil, amlodipine and hydrochlorothiazide Camber Pharmaceuticals, Inc. 2025-10-06
31722-0895-90 90 TABLET, FILM COATED in 1 BOTTLE (31722-895-90) Olmesartan medoxomil, amlodipine and hydrochlorothiazide Camber Pharmaceuticals, Inc. 2025-10-06
31722-0896-30 30 TABLET, FILM COATED in 1 BOTTLE (31722-896-30) Olmesartan medoxomil, amlodipine and hydrochlorothiazide Camber Pharmaceuticals, Inc. 2025-10-06
31722-0896-32 10 BLISTER PACK in 1 CARTON (31722-896-32) / 10 TABLET, FIL... Olmesartan medoxomil, amlodipine and hydrochlorothiazide Camber Pharmaceuticals, Inc. 2025-10-06
31722-0896-90 90 TABLET, FILM COATED in 1 BOTTLE (31722-896-90) Olmesartan medoxomil, amlodipine and hydrochlorothiazide Camber Pharmaceuticals, Inc. 2025-10-06
33342-0243-07 30 TABLET, FILM COATED in 1 BOTTLE (33342-243-07) Olmesartan medoxomil Amlodipine and Hydrochlorothiazide Macleods Pharmaceuticals Limited 2025-07-18
33342-0243-10 90 TABLET, FILM COATED in 1 BOTTLE (33342-243-10) Olmesartan medoxomil Amlodipine and Hydrochlorothiazide Macleods Pharmaceuticals Limited 2025-07-18
33342-0244-07 30 TABLET, FILM COATED in 1 BOTTLE (33342-244-07) Olmesartan medoxomil Amlodipine and Hydrochlorothiazide Macleods Pharmaceuticals Limited 2025-07-18
33342-0244-10 90 TABLET, FILM COATED in 1 BOTTLE (33342-244-10) Olmesartan medoxomil Amlodipine and Hydrochlorothiazide Macleods Pharmaceuticals Limited 2025-07-18
33342-0245-07 30 TABLET, FILM COATED in 1 BOTTLE (33342-245-07) Olmesartan medoxomil Amlodipine and Hydrochlorothiazide Macleods Pharmaceuticals Limited 2025-07-18
33342-0245-10 90 TABLET, FILM COATED in 1 BOTTLE (33342-245-10) Olmesartan medoxomil Amlodipine and Hydrochlorothiazide Macleods Pharmaceuticals Limited 2025-07-18
33342-0246-07 30 TABLET, FILM COATED in 1 BOTTLE (33342-246-07) Olmesartan medoxomil Amlodipine and Hydrochlorothiazide Macleods Pharmaceuticals Limited 2025-07-18
33342-0246-10 90 TABLET, FILM COATED in 1 BOTTLE (33342-246-10) Olmesartan medoxomil Amlodipine and Hydrochlorothiazide Macleods Pharmaceuticals Limited 2025-07-18
33342-0247-07 30 TABLET, FILM COATED in 1 BOTTLE (33342-247-07) Olmesartan medoxomil Amlodipine and Hydrochlorothiazide Macleods Pharmaceuticals Limited 2025-07-18
33342-0247-10 90 TABLET, FILM COATED in 1 BOTTLE (33342-247-10) Olmesartan medoxomil Amlodipine and Hydrochlorothiazide Macleods Pharmaceuticals Limited 2025-07-18
42571-0245-05 500 TABLET, FILM COATED in 1 BOTTLE (42571-245-05) OLMESARTAN MEDOXOMIL, AMLODIPINE and HYDROCHLOROTHIAZIDE Micro Labs Limited 2026-03-01
42571-0245-10 1000 TABLET, FILM COATED in 1 BOTTLE (42571-245-10) OLMESARTAN MEDOXOMIL, AMLODIPINE and HYDROCHLOROTHIAZIDE Micro Labs Limited 2026-03-01
42571-0245-30 30 TABLET, FILM COATED in 1 BOTTLE (42571-245-30) OLMESARTAN MEDOXOMIL, AMLODIPINE and HYDROCHLOROTHIAZIDE Micro Labs Limited 2026-03-01
42571-0245-90 90 TABLET, FILM COATED in 1 BOTTLE (42571-245-90) OLMESARTAN MEDOXOMIL, AMLODIPINE and HYDROCHLOROTHIAZIDE Micro Labs Limited 2026-03-01
42571-0246-05 500 TABLET, FILM COATED in 1 BOTTLE (42571-246-05) OLMESARTAN MEDOXOMIL, AMLODIPINE and HYDROCHLOROTHIAZIDE Micro Labs Limited 2026-03-01
42571-0246-10 1000 TABLET, FILM COATED in 1 BOTTLE (42571-246-10) OLMESARTAN MEDOXOMIL, AMLODIPINE and HYDROCHLOROTHIAZIDE Micro Labs Limited 2026-03-01
42571-0246-30 30 TABLET, FILM COATED in 1 BOTTLE (42571-246-30) OLMESARTAN MEDOXOMIL, AMLODIPINE and HYDROCHLOROTHIAZIDE Micro Labs Limited 2026-03-01
42571-0246-90 90 TABLET, FILM COATED in 1 BOTTLE (42571-246-90) OLMESARTAN MEDOXOMIL, AMLODIPINE and HYDROCHLOROTHIAZIDE Micro Labs Limited 2026-03-01
42571-0247-05 500 TABLET, FILM COATED in 1 BOTTLE (42571-247-05) OLMESARTAN MEDOXOMIL, AMLODIPINE and HYDROCHLOROTHIAZIDE Micro Labs Limited 2026-03-01
42571-0247-10 1000 TABLET, FILM COATED in 1 BOTTLE (42571-247-10) OLMESARTAN MEDOXOMIL, AMLODIPINE and HYDROCHLOROTHIAZIDE Micro Labs Limited 2026-03-01
42571-0247-30 30 TABLET, FILM COATED in 1 BOTTLE (42571-247-30) OLMESARTAN MEDOXOMIL, AMLODIPINE and HYDROCHLOROTHIAZIDE Micro Labs Limited 2026-03-01
42571-0247-90 90 TABLET, FILM COATED in 1 BOTTLE (42571-247-90) OLMESARTAN MEDOXOMIL, AMLODIPINE and HYDROCHLOROTHIAZIDE Micro Labs Limited 2026-03-01
42571-0248-05 500 TABLET, FILM COATED in 1 BOTTLE (42571-248-05) OLMESARTAN MEDOXOMIL, AMLODIPINE and HYDROCHLOROTHIAZIDE Micro Labs Limited 2026-03-01
42571-0248-10 1000 TABLET, FILM COATED in 1 BOTTLE (42571-248-10) OLMESARTAN MEDOXOMIL, AMLODIPINE and HYDROCHLOROTHIAZIDE Micro Labs Limited 2026-03-01
42571-0248-30 30 TABLET, FILM COATED in 1 BOTTLE (42571-248-30) OLMESARTAN MEDOXOMIL, AMLODIPINE and HYDROCHLOROTHIAZIDE Micro Labs Limited 2026-03-01
Observed labelers: Micro Labs Limited (20) · Camber Pharmaceuticals, Inc. (15) · Macleods Pharmaceuticals Limited (10) · Par Health USA, LLC (10) · Slate Run Pharmaceuticals, LLC (10) · Cosette Pharmaceuticals, Inc. (5) · +2 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.